# Efficacy Study of Cardizem in Pulmonary Arterial Hypertension

> **NCT01645826** · NA · WITHDRAWN · sponsor: **University of South Florida**

## Conditions studied

- Idiopathic Pulmonary Arterial Hypertension
- Primary Pulmonary Hypertension
- Pulmonary Arterial Hypertension
- Familial Primary Pulmonary Hypertension

## Interventions

- **DRUG:** Diltiazem Hydrochloride
- **DRUG:** Sugar Pill

## Key facts

- **NCT ID:** NCT01645826
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-07
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no participants agreed to enroll since study start
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01645826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01645826, "Efficacy Study of Cardizem in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01645826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*